- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01736280
Evaluating and Treating Potential Research Participants With Digestive Disorders
Evaluation and Treatment Protocol for Potential Research Participants With Digestive Disorders
Background:
- Some research studies focus on digestive disorders, such as nutritional, gastrointestinal, and liver disorders. Researchers want to examine and treat people with digestive disorders in order to learn more about these disorders. They also want to study how digestive disorders run in some families. To do so, they will provide standard care to people with digestive disorders. They will also look at relatives of people with digestive disorders, such as parents, children, and siblings.
Objectives:
- To examine and treat people with digestive disorders.
- To evaluate people with digestive disorders for research studies.
Eligibility:
- Individuals of any age who have digestive disorders.
- Individuals at least 2 years of age who are first-degree relatives of the people with digestive disorders.
Design:
- Participants will have at least one outpatient visit to the National Institutes of Health. The visit will last about 2 hours.
- All participants will be screened with a physical exam and medical history. They will also provide different samples for study. Samples may include blood, urine, and stool samples. Saliva and hair samples may also be taken. Skin biopsies and rectal swabs may be collected from adult participants.
- Participants with digestive disorders may be able to receive treatment through this study.
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
The National Institute of Nursing Research (NINR) is conducting a protocol to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed digestive conditions. Investigators of this protocol provide GI consultation at the NIH Clinical Center for a range of GI conditions.
Objectives: The primary objective of this protocol is to allow digestive care specialists in NINR and other institutions to provide standard of care. Evaluating and treating participants will allow digestive care specialists to maintain their expertise and gain additional knowledge of the course of various digestive disorders. Additionally this protocol will allow for hypothesis generation and provide a resource of patients for enrollment into new research protocols throughout the NINR branches. The information obtained will allow for the evaluation of standard treatments of the studied digestive diseases. This understanding may lead to ideas for future protocols. The protocol will also allow for trainees to receive training in the management of digestive disorders.
Study Population: The number of participants for this evaluation and treatment protocol will be set to 500 patients with digestive disorders and their unaffected first-degree relatives.
Design: This is a natural history evaluation and treatment protocol of the progression and physiology of multiple digestive disorders. Blood or other biologic samples (including but not limited to stool, urine, saliva, hair, cheek swab, or tissue) will be obtained through non-invasive means or incidentally to clinical care for future laboratory studies. In addition, genetic samples may be collected from unaffected first-degree relatives and may be used to identify and verify causative mutations.
Outcome Measures: The outcome measures for this protocol are the clinical assessments of enrolled participants, including their response to standard treatments. Also, causative mutations may help establish pathogenic mechanisms and genotype-phenotype correlations.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Maryland
-
Bethesda, Maryland, Spojené státy, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
- INCLUSION CRITERIA:
This protocol will include participants from birth and has no upper age limit.
Participants will be eligible if they:
- Have either a digestive disorder, OR
- Are an unaffected first-degree relative ( >2 years old) of a participant with a digestive disorder.
EXCLUSION CRITERIA:<TAB>
Participants will not be eligible if they:
- Are unwilling to give informed consent or, if a minor, do not have a parent or guardian able to provide consent, cannot assign a Durable Power of Attorney (DPA) or if a minor, do not have a parent or guardian able to provide consent.
- Have a systemic disease that, in the judgment of the investigators, compromises the ability to obtain research data.
- NINR employees, subordinates/relatives/ or co-workers
- Any NIH employess who is a subordinate/relative/or co-worker of a study investigator
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Jiný: 1
Standard of Care.
Participants will be evaluated and treated for their particular digestive disorder or presenting symptoms.
|
Any evaluation or treatment under this protocol will be based on standard practice as related to the subjects's digestive disorder.These include but are not limited to biobehavioral interventions including bowel retraining, biofeedback, and other lifestyle interventions, all of which have been shown to be beneficial in the treatment of this type of chronic functional bowel disorder.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Evaluation and treatment of GI disorders
Časové okno: Outcomes will be assessed periodically according to disorder and severity.
|
This protocol allows NINR investigators to provide treatment for GI disorders and maintain knowledge and expertise of GI disorders.
|
Outcomes will be assessed periodically according to disorder and severity.
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Wendy A Henderson, C.R.N.P., National Institute of Nursing Research (NINR)
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 120195
- 12-NR-0195
Informace o lécích a zařízeních, studijní dokumenty
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Standard of Care
-
University of MinnesotaNational Institute of Mental Health (NIMH)Dokončeno
-
The Cleveland ClinicSanten Inc.Aktivní, ne nábor
-
HeNan Sincere Biotech Co., LtdNeznámý
-
Medstar Health Research InstituteNational Institutes of Health (NIH); Georgetown-Howard Universities Center... a další spolupracovníciDokončenoSrdeční selhání | Městnavé srdeční selháníSpojené státy
-
Summa Therapeutics, LLCZatím nenabírámePeriferní arteriální onemocnění pod kolenem | Periferní arteriální onemocnění, Rutherford 4 a 5 s možností zlepšení vaskularizaceSpojené státy
-
Hospices Civils de LyonNáborTrauma; KomplikaceFrancie
-
University of Southern California3MStaženoHojení ran | Dehiscence rány
-
The First Hospital of Jilin UniversityDokončenoRakovina konečníkuČína
-
Allegheny Singer Research Institute (also known...AtriCure, Inc.Aktivní, ne náborBolest, pooperační | Účinek kryoterapieSpojené státy